Search
Search Results
##search.searchResults.foundPlural##
-
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4355PDF: 1522HTML: 1555Untitled: 239 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3372PDF: 1978HTML: 7479 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1292PDF: 477HTML: 18612Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1108PDF: 861HTML: 107 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
895PDF: 669HTML: 228 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
902PDF: 675HTML: 113 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7660PDF: 2446HTML: 1740Table 1.: 214Table 2.: 224Table 3.: 208Table 4.: 209 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2493PDF: 874HTML: 2393 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1090PDF: 968HTML: 340 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3257PDF: 1024HTML: 2033 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3063PDF: 1031HTML: 3094 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1402HTML: 475PDF: 834 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1016PDF: 553HTML: 7816 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4109PDF: 1258HTML: 1962Table 1: 203 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1315PDF: 734HTML: 330 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2533PDF: 947HTML: 306 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1378PDF: 769HTML: 524 -
ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia
1273PDF: 740HTML: 212







